Biotech - Press Releases

Date	Title	Company
22-Jan-2020	Abeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis Bullosa	Abeona Therapeutics
22-Jan-2020	Novartis receives European licence for Mayzent®▼(siponimod), the first oral treatment for secondary progressive multiple sclerosis (SPMS) with active disease	Novartis
22-Jan-2020	Polaryx Therapeutics Receives IND Approval for PLX-200 From the FDA for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis	Polaryx Therapeutics, Inc
22-Jan-2020	PredictImmune announces commercial partnership with Cambridge Clinical Laboratories (CCL) to promote and supply PredictSURE IBD™, the world’s first validated prognostic test for inflammatory bowel disease	PredictImmune
22-Jan-2020	Bioprocessing Summit Europe Returns March 24-26, 2020 in Barcelona with New Analytical and Formulation Sessions	Cambridge Healthtech Institute
22-Jan-2020	European Commission Approves Darzalex®▼ (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible	The Janssen Pharmaceutical Companies of Johnson & Johnson
22-Jan-2020	Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma	Genmab
22-Jan-2020	HepaRegeniX GmbH Secures Series B Financing in Excess of €11 Mio. to Advance First Drug Candidate to the Clinic	HepaRegeniX GmbH
22-Jan-2020	7MM to see sepsis cases grow to 3.1 million by 2026, says GlobalData	GlobalData
22-Jan-2020	Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases	Quest Diagnostics
22-Jan-2020	Akron Biotechnology publishes industry-wide recommendations for ATMP ancillary material regulation	Akron Biotechnology
22-Jan-2020	Soin Neuroscience Develops A New Spinal Cord Stimulator to Treat Chronic Pain	Soin Neuroscience
21-Jan-2020	FDA approves first treatment for thyroid eye disease	U.S. Food and Drug Administration
21-Jan-2020	Spherix Launches Newly Redesigned Website	Spherix Incorporated
21-Jan-2020	Exscientia appoints Dr. David Hallett as Chief Operating Officer as company positions for further growth	Exscientia
21-Jan-2020	NORGINE WELCOMES NEW GENERAL MANAGER FOR GERMANY	Norgine B.V.
21-Jan-2020	SMi’s Pharmaceutical Microbiology in Boston - what to expect over the 2 day conference	SMi Group
21-Jan-2020	Diaprost Announces Exercise of Option Under the Terms of its Research and Option Agreement With a Leading Pharmaceutical Company	Diaprost AB
20-Jan-2020	Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2019 Financial Results	Neurocrine Biosciences, Inc.
20-Jan-2020	Transcenta Announces Acceptance by NMPA of IND Application of a Novel Humanized Claudin 18.2 Monoclonal Antibody	Transcenta Holding